James P. Boylan - Mar 8, 2024 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role: Director
Signature: /s/ Neil Lerner, as attorney-in-fact
Stock symbol: CMPX
Transactions as of: Mar 8, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/11/2024, 10:12 AM
Previous filing: Oct 31, 2023
Next filing: Jun 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMPX	Stock Option (Right to Buy)	Award	$0	+40K		$0.00	40K	Mar 8, 2024	Common Stock	40K	$1.96	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest over 48 substantially equal monthly installments starting April 8, 2024.
F2	The Reporting Person is a member of Enavate Sciences, LP ("Enavate"). Pursuant to an agreement with Enavate, the Reporting Person has agreed to receive and hold for the benefit of Enavate any securities issued under any stock options or other awards granted to him for his services as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the reported securities.

Content

The options vest over 48 substantially equal monthly installments starting April 8, 2024.

The Reporting Person is a member of Enavate Sciences, LP ("Enavate"). Pursuant to an agreement with Enavate, the Reporting Person has agreed to receive and hold for the benefit of Enavate any securities issued under any stock options or other awards granted to him for his services as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the reported securities.